Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

COVID-19 RESEARCH

COVID-19 RESEARCH

ARENSIA has contributed to numerous research projects with innovative compounds enrolling more than 1,500 COVID-19 patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

NEWS ABOUT UKRAINE

UKRAINE APPROVES CLINICAL TRIALS IN 35 DAYS UKRAINE APPROVES CLINICAL TRIALS IN 35 DAYS 30.03.2023

The Ministry of Health (MoH) of Ukraine has just published new approval timelines for Clinical Studies of 35 calendar days, down from 60 days. The change is in place as of now! (MoH order N190 dated 31st Jan 2023 and approved by Ministry of Justice o...

1 YEAR OF WAR IN UKRAINE 1 YEAR OF WAR IN UKRAINE 17.02.2023

Our entire ARENSIA family is proud of our incredible team in Ukraine, who have continued to work tirelessly during the challenges of this past year. Their resilience and commitment to excellence in the face of adversity are an inspiration to us all. ...

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS IN KYIV, UKRAINE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS IN KYIV, UKRAINE 20.01.2023

ARENSIA clinic in Kyiv started the New Year by administering an innovative drug to patients with paroxysmal nocturnal hemoglobinuria (PNH). Happy to share impressions of a patient visit to our clinic. Among another 12 sites opened worldwide to con...

UKRAINE UPDATE UKRAINE UPDATE 13.10.2022

The last few days saw an increase in hostilities. While condemning the aggression, one needs to put it into perspective as being made only of despicable acts of state terror, very visible but superficial, neither causing heavy losses nor seriously im...

LATEST PERFORMANCE AT ARENSIA CLINIC IN KYIV, UKRAINE LATEST PERFORMANCE AT ARENSIA CLINIC IN KYIV, UKRAINE 16.08.2022

12 patients with Ulcerative Colitis in a Phase 2a exploratory trial have been screened in the last three weeks. The first one was dosed today. Across all ARENSIA studies in Kyiv, all patients’ visits happen per schedule, same for samples arr...

UPDATES: ARENSIA Research Clinic, Kyiv, Ukraine UPDATES: ARENSIA Research Clinic, Kyiv, Ukraine 21.07.2022

Today, ARENSIA research clinic in Kyiv, Ukraine has screened its first patient since the Russian aggression on Feb 24, 2022! The Sponsor, a US based biopharmaceutical company has proven its committment to Ukraine by enabling our patients the acces...

UPDATE UKRAINE: PATIENTS COME FIRST! UPDATE UKRAINE: PATIENTS COME FIRST! 29.03.2022

Patients come first! It has been a huge undertaking by ARENSIA’s teams in Moldova and Ukraine, our Sponsors, and multiple partners to make sure that our patients from Ukraine have an opportunity to continue their treatment at ARENSIA Clinics in...

UPDATE: UKRANIAN TEAM UPDATE: UKRANIAN TEAM 11.03.2022

ARENSIA thanks everyone for the overwhelming support and care for our Ukrainian team! We are glad to inform that all members of ARENSIA Ukraine team are accounted for and safe. We stay fully committed to our talented and brave colleagues and offer th...

WE STAY FULLY COMMITTED TO UKRAINE DURING THIS TIME! WE STAY FULLY COMMITTED TO UKRAINE DURING THIS TIME! 01.03.2022

ARENSIA stays fully committed to Ukraine during this time! We have an exceptionally brave and dedicated team in Kyiv, of whom we are so proud! Thankfully, they and their families are all safe! ARENSIA Clinics remains functional. We stay closely...

VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse